SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-004396
Filing Date
2021-01-15
Accepted
2021-01-15 06:03:00
Documents
76
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nwbo-20200930x10q.htm   iXBRL 10-Q 2620308
2 EXHIBIT 31.1 nwbo-20200930xex31d1.htm EX-31.1 13303
3 EXHIBIT 32.1 nwbo-20200930xex32d1.htm EX-32.1 9045
  Complete submission text file 0001104659-21-004396.txt   11951536

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20200930.xsd EX-101.SCH 73680
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20200930_cal.xml EX-101.CAL 59203
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20200930_def.xml EX-101.DEF 299359
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20200930_lab.xml EX-101.LAB 511251
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20200930_pre.xml EX-101.PRE 489880
9 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20200930x10q_htm.xml XML 2821841
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 21530448
SIC: 2834 Pharmaceutical Preparations